Juvenescence Ltd - Insider Non-Derivative Transactions at AgeX Therapeutics, Inc. (AGE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 14, 2023, Juvenescence Ltd's relationship to AgeX Therapeutics, Inc. (AGE) is Director,TenPercentOwner, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AGE insiders.
Data Source: SEC.
Juvenescence Ltd - Insider Non-Derivative Transactions at AGE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 15, 2023 | G -- (Common Stock) | 16447500 | 0 | 0 |